146 related articles for article (PubMed ID: 1905553)
1. Prevalence of HIV-1 p24 antigenemia in African and North American populations and correlation with clinical status.
Brown C; Kline R; Atibu L; Francis H; Ryder R; Quinn TC
AIDS; 1991 Jan; 5(1):89-92. PubMed ID: 1905553
[TBL] [Abstract][Full Text] [Related]
2. Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia.
MacDonell KB; Chmiel JS; Poggensee L; Wu S; Phair JP
Am J Med; 1990 Dec; 89(6):706-12. PubMed ID: 1979205
[TBL] [Abstract][Full Text] [Related]
3. Sensitive one-step enzyme immunoassay for HIV-1 p24 antigen in human blood specimens and cell culture supernatants.
Kontio S
J Immunol Methods; 1991 Jun; 139(2):257-63. PubMed ID: 1904466
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 P24 antigenaemia does not predict time of survival in AIDS patients.
Mulder JW; Krijnen P; Goudsmit J; Schattenkerk JK; Reiss P; Lange JM
Genitourin Med; 1990 Jun; 66(3):138-41. PubMed ID: 2115018
[TBL] [Abstract][Full Text] [Related]
5. An ELISA-inhibition assay for antibody to human immunodeficiency virus core antigen (p24).
Povolotsky J; Gold JW; Darminin P; Chein N; Baron P; Armstrong D
J Virol Methods; 1990 Oct; 30(1):109-14. PubMed ID: 2128300
[TBL] [Abstract][Full Text] [Related]
6. Free and decomplexed human immunodeficiency virus p24 antigenaemia in black patients with AIDS and AIDS-related disorders.
Bélec L; Matta M; Di Costanzo B; Dragon MA; Grésenguet G; Mbopi Kéou FX; Payan C
Eur J Med; 1993; 2(8):478-83. PubMed ID: 8258048
[TBL] [Abstract][Full Text] [Related]
7. A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals.
Nishanian P; Huskins KR; Stehn S; Detels R; Fahey JL
J Infect Dis; 1990 Jul; 162(1):21-8. PubMed ID: 2113075
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and persistence of antibody titers to recombinant HIV-1 core and matrix proteins in HIV-1 infection.
Janvier B; Mallet F; Cheynet V; Dalbon P; Vernet G; Besnier JM; Choutet P; Goudeau A; Mandrand B; Barin F
J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):898-903. PubMed ID: 8315575
[TBL] [Abstract][Full Text] [Related]
9. Humoral aspects of anti-HIV immune responses in Zairians with AIDS: lower antigenemia does not correlate with immune complex levels.
Kashala O; Kayembe K; Kanki P; Mukeba P; Diese M; Kalengayi M; Izzia KW; Essex M
AIDS Res Hum Retroviruses; 1993 Mar; 9(3):251-8. PubMed ID: 8471316
[TBL] [Abstract][Full Text] [Related]
10. Racial heterogeneity of HIV antigenemia in people with HIV infection.
Chaisson RE; Fuchs E; Stanton DL; Quinn TC; Hendricksen C; Bartlett JG; Farzadegan H
AIDS; 1991 Feb; 5(2):177-80. PubMed ID: 1903261
[TBL] [Abstract][Full Text] [Related]
11. Donor HIV-1 p24 antigenaemia and course of infection in recipients Transfusion Safety Study Group.
Busch MP; Donegan E; Stuart M; Mosley JW
Lancet; 1990 Jun; 335(8701):1342. PubMed ID: 1971398
[No Abstract] [Full Text] [Related]
12. Kinetics of p24 antigenemia, IgM, IgG antibodies to p24 and p41 and Ig virus isolation in rabbits experimentally infected with HIV-1.
Filice G; Cereda PM; Orsolini P; Soldini L; Romero E; Rondanelli EG
Microbiologica; 1990 Jul; 13(3):215-24. PubMed ID: 2125683
[TBL] [Abstract][Full Text] [Related]
13. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection].
Sorice F; Vullo V; Cirelli A; Catania S; Mastroianni CM; Contini C; Delia S
Boll Ist Sieroter Milan; 1989; 68(2):115-21. PubMed ID: 2562362
[TBL] [Abstract][Full Text] [Related]
14. [The clinical and immunological correlations between the p24 antigenemia levels and those of anti-p24 antibodies in HIV-seropositive children].
Apetrei C; Buzdugan I; Mitroi I; Duca M
Bacteriol Virusol Parazitol Epidemiol; 1995; 40(2):141-4. PubMed ID: 7549257
[TBL] [Abstract][Full Text] [Related]
15. Response of serum p24 antigen and antibody to p24 antigen in patients with AIDS and AIDS-related complex treated with zidovudine.
Williams IG; Gabriel G; Kelly G; Loveday C; Tedder RS; Weller IV
AIDS; 1990 Sep; 4(9):909-12. PubMed ID: 2123627
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of quantitative levels of HIV p24 binding capacity in HIV infection.
Croxson TS; Mathur-Wagh U; Handwerger S; Siroty WE; Kaminisky D; Reagan KJ; Yancovitz SR; Mildvan D
AIDS Res Hum Retroviruses; 1990 Apr; 6(4):455-63. PubMed ID: 2111160
[TBL] [Abstract][Full Text] [Related]
17. Immune activation markers and AIDS prognosis.
Osmond DH; Shiboski S; Bacchetti P; Winger EE; Moss AR
AIDS; 1991 May; 5(5):505-11. PubMed ID: 1677808
[TBL] [Abstract][Full Text] [Related]
18. [Dynamics of the antibody response and p24 antigenemia in HIV-1 infected individuals in Czechoslovakia].
Kopecká D; Brůcková M; Stanková M; Syrůcek L; Vojtĕchovský K; Petkov V
Cesk Epidemiol Mikrobiol Imunol; 1990 Mar; 39(2):65-73. PubMed ID: 2142624
[TBL] [Abstract][Full Text] [Related]
19. Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individuals.
Reiss P; de Wolf F; Kuiken CL; de Ronde A; Dekker J; Boucher CA; Debouck C; Lange JM; Goudsmit J
J Acquir Immune Defic Syndr (1988); 1991; 4(2):165-72. PubMed ID: 1898969
[TBL] [Abstract][Full Text] [Related]
20. Free and antibody-complexed antigen and antibody profile in apparently healthy HIV seropositive individuals and in AIDS patients.
Portera M; Vitale F; La Licata R; Alesi DR; Lupo G; Bonura F; Romano N; Di Cuonzo G
J Med Virol; 1990 Jan; 30(1):30-5. PubMed ID: 2106004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]